Krystal BiotechListed
krystalbiotech.combiotech_life_sciences
Krystal Biotech is a biotechnology company focused on developing and commercializing genetic medicines for patients with rare diseases. The company’s first commercial product, VYJ…
Portfolio
A closer look at the companies associated with this firm. Verified team members can update the portfolio after signing in.
This is the portfolio currently shown on the public firm page.
Krystal Biotech is a biotechnology company focused on developing and commercializing genetic medicines for patients with rare diseases. The company’s first commercial product, VYJ…
Arcutis Biotherapeutics is a clinical-stage biopharmaceutical company focused on developing meaningful innovations in immuno-dermatology, addressing significant unmet needs in the…
BridgeBio is focused on developing meaningful medicines for patients with genetic conditions, utilizing a decentralized model that emphasizes speed and precision in drug developme…
Tubulis generates uniquely matched antibody-drug conjugates with superior biophysical properties that have demonstrated durable on-tumor delivery and long-lasting anti-tumor activ…
KalVista Pharmaceuticals is a global biopharmaceutical company dedicated to developing and delivering life-changing oral therapies for individuals affected by rare diseases with s…
Vaxcyte is focused on developing innovative vaccines to address unmet medical needs in infectious diseases and cancer.
Chimerix is a biopharmaceutical company focused on developing innovative medicines for patients with rare diseases, particularly those with limited or no therapeutic options. They…
Cidara Therapeutics is a research-intensive biopharmaceutical company focused on developing important medicines and vaccines, particularly in areas such as oncology, infectious di…
Collegium Pharmaceutical is a biopharmaceutical company committed to improving the lives of people living with serious medical conditions.
Erasca is a clinical-stage precision oncology company focused on discovering and developing therapies to treat cancer.
Harnessing breakthrough science to advance hematology care, focusing on innovative treatments for hematologic diseases.
NewAmsterdam Pharma is a biopharmaceutical company focused on developing treatments for metabolic diseases, particularly cardiovascular disease. It investigates obicetrapib for lo…
Palvella Therapeutics is a clinical-stage biopharmaceutical company focused on developing and commercializing novel therapies to treat patients suffering from serious, rare skin d…
Mirum Pharmaceuticals is a high-growth company focused on developing treatments for rare diseases, particularly cholestatic liver diseases. The company aims to address significant…
Phathom Pharmaceuticals is a biopharmaceutical company focused on developing and commercializing novel treatments for gastrointestinal (GI) diseases, including VOQUEZNA® for GERD…
Reata Pharmaceuticals Inc operates in the pharmaceutical and healthcare industry that develops therapeutics for the treatment of neurodegenerative diseases.
Cerevel Therapeutics is a biopharmaceutical company focused on developing new therapies to treat disorders of the central nervous system (CNS). The company has a portfolio of expe…
Amicus Therapeutics is a biotechnology company focused on developing medicines for people living with genetically defined conditions, particularly in the rare disease sector.
AnaptysBio, Inc. is focused on managing the financial collaborations for Jemperli with GSK and imsidolimab with Vanda, with a strategic emphasis on delivering shareholder value.
Rigel Pharmaceuticals is a biotechnology company dedicated to discovering, developing and providing novel therapies that significantly improve the lives of patients with hematolog…
Trillium is a clinical stage immuno-oncology company developing innovative therapies for the treatment of cancer, focusing on CD47 programs and SIRPα-Fc fusion proteins.
Maze Therapeutics is a clinical-stage biopharmaceutical company focused on developing breakthrough precision medicines for common diseases, particularly chronic kidney disease, le…
MBX Biosciences is a biopharmaceutical company focused on developing precision peptide therapies for endocrine and metabolic disorders, utilizing its proprietary PEP™ platform.
Passage Bio is a clinical stage genetic medicines company focused on improving the lives of patients with neurodegenerative diseases through the development of innovative gene the…
Verona Pharma is developing novel treatments to enhance the lives of those affected by chronic lung conditions.
Tarsus Pharmaceuticals is a biopharmaceutical company dedicated to creating new categories in eye care and beyond, focusing on diseases with high unmet needs. They have developed…
Attovia Therapeutics is a clinical-stage biopharmaceutical company focused on immune-mediated diseases, developing next-generation biologic therapies using its proprietary ATTOBOD…
Braveheart Bio is focused on transforming the care of hypertrophic cardiomyopathy (HCM) through innovative treatments like BHB-1893, a cardiac myosin inhibitor aimed at improving…
Parabilis is a clinical-stage biopharmaceutical company dedicated to creating extraordinary medicines for patients with serious diseases by unlocking biologically important target…
AirNexis Therapeutics is a biopharmaceutical company dedicated to developing innovative therapies that address unmet medical needs in oncology and autoimmune disorders.
Crystalys Therapeutics is a biotechnology company specializing in the development and commercialization of therapeutic products, focusing on treatments for serious respiratory dis…